Matching samples

RNA-seq CD NOD2 after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701327
sample_title: RNA-seq CD NOD2 after MDP, replicate1
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HOM SNP13 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq CD NOD2 after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701328
sample_title: RNA-seq CD NOD2 after MDP, replicate2
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP12 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq CD NOD2 after MDP, replicate3

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701329
sample_title: RNA-seq CD NOD2 after MDP, replicate3
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP8 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq CD NOD2 before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701330
sample_title: RNA-seq CD NOD2 before MDP, replicate1
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HOM SNP13 + WT ATG16L1; treatment: unstimulated

RNA-seq CD NOD2 before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701331
sample_title: RNA-seq CD NOD2 before MDP, replicate2
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP12 + WT ATG16L1; treatment: unstimulated

RNA-seq CD NOD2 before MDP, replicate3

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701332
sample_title: RNA-seq CD NOD2 before MDP, replicate3
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP8 + WT ATG16L1; treatment: unstimulated

RNA-seq CD WT after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701333
sample_title: RNA-seq CD WT after MDP, replicate1
source_name: Monocytes, CD, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq CD WT after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701334
sample_title: RNA-seq CD WT after MDP, replicate2
source_name: Monocytes, CD, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq CD WT before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701335
sample_title: RNA-seq CD WT before MDP, replicate1
source_name: Monocytes, CD, WT, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

RNA-seq CD WT before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701336
sample_title: RNA-seq CD WT before MDP, replicate2
source_name: Monocytes, CD, WT, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

RNA-seq healthy control after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701337
sample_title: RNA-seq healthy control after MDP, replicate1
source_name: Monocytes, healthy, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq healthy control after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701338
sample_title: RNA-seq healthy control after MDP, replicate2
source_name: Monocytes, healthy, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

RNA-seq healthy control before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701339
sample_title: RNA-seq healthy control before MDP, replicate1
source_name: Monocytes, healthy, WT, unstimulated
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

RNA-seq healthy control before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701340
sample_title: RNA-seq healthy control before MDP, replicate2
source_name: Monocytes, healthy, WT, unstimulated
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

small RNA-seq CD NOD2 after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701341
sample_title: small RNA-seq CD NOD2 after MDP, replicate1
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HOM SNP13 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq CD NOD2 after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701342
sample_title: small RNA-seq CD NOD2 after MDP, replicate2
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP12 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq CD NOD2 after MDP, replicate3

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701343
sample_title: small RNA-seq CD NOD2 after MDP, replicate3
source_name: Monocytes, CD, NOD2 SNP, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP8 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq CD NOD2 before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701344
sample_title: small RNA-seq CD NOD2 before MDP, replicate1
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HOM SNP13 + WT ATG16L1; treatment: unstimulated

small RNA-seq CD NOD2 before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701345
sample_title: small RNA-seq CD NOD2 before MDP, replicate2
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP12 + WT ATG16L1; treatment: unstimulated

small RNA-seq CD NOD2 before MDP, replicate3

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701346
sample_title: small RNA-seq CD NOD2 before MDP, replicate3
source_name: Monocytes, CD, NOD2 SNP, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: HET SNP13/HET SNP8 + WT ATG16L1; treatment: unstimulated

small RNA-seq CD WT after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701347
sample_title: small RNA-seq CD WT after MDP, replicate1
source_name: Monocytes, CD, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq CD WT after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701348
sample_title: small RNA-seq CD WT after MDP, replicate2
source_name: Monocytes, CD, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq CD WT before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701349
sample_title: small RNA-seq CD WT before MDP, replicate1
source_name: Monocytes, CD, WT, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

small RNA-seq CD WT before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701350
sample_title: small RNA-seq CD WT before MDP, replicate2
source_name: Monocytes, CD, WT, unstimulated
characteristics: cell type: monocytes; disease status: Crohn's disease; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

small RNA-seq ctrl_after MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701351
sample_title: small RNA-seq ctrl_after MDP, replicate1
source_name: Monocytes, healthy, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq ctrl_after MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment case marker detected.

sample_accession: GSM1701352
sample_title: small RNA-seq ctrl_after MDP, replicate2
source_name: Monocytes, healthy, WT, stimulated with MDP
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: stimulated with muramyl dipeptide (MDP)

small RNA-seq ctrl_before MDP, replicate1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701353
sample_title: small RNA-seq ctrl_before MDP, replicate1
source_name: Monocytes, healthy, WT, unstimulated
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated

small RNA-seq ctrl_before MDP, replicate2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1701354
sample_title: small RNA-seq ctrl_before MDP, replicate2
source_name: Monocytes, healthy, WT, unstimulated
characteristics: cell type: monocytes; disease status: healthy; genotype: WT NOD2 + WT ATG16L1; treatment: unstimulated